My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions. Conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts, with ease.
About Us
Plans & Pricing
Horizon Therapeutics (HZNP)
NASDAQ:HZNP
HZNPHorizon Therapeutics
$110.37
$0.88 (0.8%)

Horizon Therapeutics Insider Trading Activity

Trend: Corporate Insiders Sold Shares Worth $8.6M in the Last 3 Months.

HZNP Insider Transactions

The data in the graph is based on publicly available reports of insider transactions, as reported to the SEC.
See the number of informative buy and sell transactions by insiders for this stock over the past year.

Insider Confidence Signal

Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on 3 informative insider transaction by 3 unique insider from last 3 months.
The sentiment expressed in the Insider Confidence Signal is based on insider transactions over the past 3 months.

Insider Buy and Sell Transactions​

Insider Name
Role
Star Ranking
Transaction
Amount
Date
Follow
SEC
Upgrade Banner
EVP and Chief Medical Officer
Uninformative Sell
$5,089,810
EVP and Chief Medical Officer
Uninformative Sell
EVP and Chief Medical Officer
Uninformative Buy
EVP and Chief Medical Officer
Uninformative Buy
EVP and Chief Medical Officer
Uninformative Sell
$329,538
EVP and Chief Medical Officer
Uninformative Sell
$5,707,220
EVP and Chief Medical Officer
Uninformative Sell
EVP and Chief Medical Officer
Uninformative Buy
EVP and Chief Medical Officer
Uninformative Buy
EVP and Chief Medical Officer
Uninformative Sell
$75,925
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis